Brief: Heartbeam announces FDA submission of Heartbeam Aimi™ product
16/08/2022 13:45
Aug 16 (Reuters) - Heartbeam Inc BEAT.O :
* HEARTBEAM ANNOUNCES FDA SUBMISSION OF HEARTBEAM AIMI™
PRODUCT
Source text for Eikon: ID:nBw5g9k84a
Further company coverage: BEAT.O
Recent news on Heartbeam
See all newsBrief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice